Inspire Medical Systems, INC Schedule 13G passive stakes

Soleus Capital Master Fund, L.P. and associated entities have reported beneficial ownership of 6.7% of Inspire Medical Systems, Inc. common stock as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, disclosing a beneficial ownership of 6.44% in Inspire Medical Systems, Inc.

Vanguard Portfolio Management has reported a beneficial ownership of 7.37% in Inspire Medical Systems Inc., holding over 2.1 million shares.

D. E. Shaw & Co., L.P. and David E. Shaw have jointly filed a Schedule 13G, reporting beneficial ownership of 5.1% of Inspire Medical Systems, Inc. common stock.

Soleus Capital has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in Inspire Medical Systems, Inc.

Wellington Management Group LLP and its affiliates have reported beneficial ownership of 8.8% of Inspire Medical Systems, Inc. common stock as of March 31, 2026.

Deerfield Management and James E. Flynn have filed an amendment to their Schedule 13G, disclosing that their beneficial ownership in Inspire Medical Systems, Inc. has fallen below the 5% threshold.

Vanguard Capital Management reports beneficial ownership of 1,469,703 shares, representing 5.1% of Inspire Medical Systems' common stock as of March 31, 2026.

Vanguard Portfolio Management has reported beneficial ownership of 5.71% of Inspire Medical Systems Inc.'s common stock as of March 31, 2026.

The Vanguard Group has reported a 0% beneficial ownership in Inspire Medical Systems Inc. following an internal realignment of its reporting structure.

Wellington Management Group LLP and its affiliates have reported a 7.6% beneficial ownership stake in Inspire Medical Systems, Inc. as of December 31, 2025.

Dragoneer Investment Group and Marc Stad report 0% beneficial ownership in Inspire Medical Systems, indicating a full divestment of their previous stake.

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have jointly reported a 5.08% beneficial ownership stake in Inspire Medical Systems, Inc.

Wasatch Advisors LP has filed an amended Schedule 13G, disclosing a 0.5% beneficial ownership stake in Inspire Medical Systems Inc, holding 135,914 shares.

BlackRock, Inc. has reported an 11.3% beneficial ownership stake in Inspire Medical Systems Inc., holding over 3.3 million shares of common stock.

FMR LLC and Abigail P. Johnson reported an aggregate beneficial ownership of 2.5% of Inspire Medical Systems Inc. common stock in an amended Schedule 13G filing.

Citadel and its affiliates, including Kenneth Griffin, have disclosed a combined beneficial ownership of 5.8% in Inspire Medical Systems, Inc., signaling a significant passive investment.

Dragoneer Investment Group, along with Marc Stad, has reported an 8.0% beneficial ownership stake in Inspire Medical Systems, Inc. as of June 30, 2025.

Wasatch Advisors LP has filed a Schedule 13G, reporting a 5.1% beneficial ownership stake in Inspire Medical Systems, Inc. as a passive investment.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a 12.6% beneficial ownership stake in Inspire Medical Systems, Inc. as of March 31, 2025.

FMR LLC and its Chairman and CEO, Abigail P. Johnson, have filed an amended Schedule 13G, disclosing a beneficial ownership of 8.3% of Inspire Medical Systems Inc.'s common stock as of December 31, 2024.